Published in Clin Exp Med on October 01, 2004
Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc (2007) 1.49
Risk factors for the progression of cystic fibrosis lung disease throughout childhood. Ann Am Thorac Soc (2014) 0.85
Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis. PLoS One (2011) 0.83
Peroxisome proliferator-activated receptor alpha (PPAR alpha) down-regulation in cystic fibrosis lymphocytes. Respir Res (2006) 0.83
Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses. Sci Adv (2015) 0.83
Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol (1983) 11.06
Identification of mutations in regions corresponding to the two putative nucleotide (ATP)-binding folds of the cystic fibrosis gene. Proc Natl Acad Sci U S A (1990) 4.74
Human actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolution. Mol Cell Biol (1983) 4.01
Integrated plasma cortisol concentration in children with asthma receiving long-term inhaled corticosteroids. Pediatr Pulmonol (1992) 2.68
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros (2008) 2.56
Cardiac actin is the major actin gene product in skeletal muscle cell differentiation in vitro. Mol Cell Biol (1984) 2.33
alpha-skeletal and alpha-cardiac actin genes are coexpressed in adult human skeletal muscle and heart. Mol Cell Biol (1983) 2.29
Congenital bilateral absence of vas deferens in the absence of cystic fibrosis. Lancet (1994) 2.22
Two-level regulation of cardiac actin gene transcription: muscle-specific modulating factors can accumulate before gene activation. Mol Cell Biol (1986) 2.13
Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med (1997) 2.10
Choosing an oestrogen replacement therapy in young adult women with Turner syndrome. Clin Endocrinol (Oxf) (2001) 1.99
Promoting older adults' well-being through Internet training and use. Aging Ment Health (2007) 1.97
Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease. Am J Hum Genet (1992) 1.85
Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am J Clin Nutr (1995) 1.74
Lung involvement and enzyme replacement therapy in Gaucher's disease. QJM (2001) 1.70
Association between mitral annulus calcification and carotid atherosclerotic disease. Stroke (1998) 1.67
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J (2011) 1.63
Cigarette smoking habits among schoolchildren. Chest (1996) 1.61
Polyuridylic acid binding and translating by Escherichia coli ribosomes: stimulation by protein I, inhibition by aurintricarboxylic acid. Biochim Biophys Acta (1972) 1.60
Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol (1998) 1.59
Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol (1997) 1.58
The molecular basis of partial penetrance of splicing mutations in cystic fibrosis. Am J Hum Genet (1997) 1.56
Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros (2011) 1.54
Prediction of mortality and timing of referral for lung transplantation in cystic fibrosis patients. Pediatr Transplant (2001) 1.53
Hospitalization for early bonding of the genetic mother after a surrogate pregnancy: report of two cases. Birth (2001) 1.52
Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids : apolipoprotein A-I stabilizes activity. Arterioscler Thromb Vasc Biol (1999) 1.47
Nitric oxide inhalation for paraquat-induced lung injury. J Toxicol Clin Toxicol (1998) 1.45
Is endotracheal adrenaline deleterious because of the beta adrenergic effect? Anesth Analg (2001) 1.43
Menstrual asthma: use of a gonadotropin-releasing hormone analogue for the treatment of cyclic aggravation of bronchial asthma. Fertil Steril (1994) 1.43
Trampoline use as physiotherapy for cystic fibrosis patients. Pediatr Pulmonol (2005) 1.42
Decreased sensitivity to insulin-like growth factor I in Turner's syndrome: a study of monocytes and T lymphocytes. Eur J Clin Invest (1997) 1.42
Nesidiodysplasia--a histologic entity? Hum Pathol (1988) 1.42
Striae distensae of augmented breasts after oral contraceptive therapy. Ann Plast Surg (1999) 1.42
Circulating leptin and the perioperative neuroendocrinological stress response after pediatric cardiac surgery. Crit Care Med (2001) 1.42
Medics in the Israel Defense Forces and their experience in trauma care during peacetime. Isr Med Assoc J (1999) 1.38
A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations. Am J Respir Crit Care Med (2000) 1.37
Factors contributing to physicians' success in the advanced trauma life support program in Israel. Isr Med Assoc J (1999) 1.36
SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents. Mol Cell Biol (1999) 1.32
Mild cystic fibrosis and normal or borderline sweat test in patients with the 3849 + 10 kb C-->T mutation. Lancet (1993) 1.32
Deposition pattern of radiolabeled salbutamol inhaled from a metered-dose inhaler by means of a spacer with mask in young children with airway obstruction. J Pediatr (1996) 1.30
Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr (1993) 1.30
Nebulized albuterol in acute bronchiolitis. J Pediatr (1990) 1.23
Pomegranate juice supplementation to atherosclerotic mice reduces macrophage lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J Nutr (2001) 1.20
Glucose-6-phosphate dehydrogenase mosaicism as a tracer in the study of hereditary multiple trichoepithelioma. Am J Hum Genet (1966) 1.19
Spiral CT and 3D image reconstruction of vascular rings and associated tracheobronchial anomalies. J Comput Assist Tomogr (1995) 1.19
Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J (2001) 1.19
Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol (2001) 1.17
The molecular basis for disease variability in cystic fibrosis. Eur J Hum Genet (1996) 1.16
Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr (1997) 1.16
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J (2005) 1.14
An interactive computer-animated system (SpiroGame) facilitates spirometry in preschool children. Am J Respir Crit Care Med (2001) 1.14
Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem Med (1983) 1.13
Phagocytosis of aggregated lipoprotein by macrophages: low density lipoprotein receptor-dependent foam-cell formation. Proc Natl Acad Sci U S A (1989) 1.12
Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye (Lond) (2005) 1.12
Long term neurological outcome of herpes encephalitis. Arch Dis Child (1999) 1.10
The improving outcome of triplet pregnancies. Am J Obstet Gynecol (1989) 1.10
On the physiological role(s) of the paraoxonases. Chem Biol Interact (1999) 1.09
Coexistence of celiac disease and eosinophilic gastroenteropathy. J Pediatr Gastroenterol Nutr (2001) 1.08
Cost-benefit analysis of a national screening programme for cystic fibrosis in an Israeli population. Health Econ (1994) 1.08
Clinical-physiologic correlations in acute asthma of childhood. Pediatrics (1991) 1.08
Simvastatin preserves coronary endothelial function in hypercholesterolemia in the absence of lipid lowering. Arterioscler Thromb Vasc Biol (2001) 1.07
Cystic fibrosis in Jews: frequency and mutation distribution. Genet Test (1997) 1.06
Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr Opin Lipidol (2001) 1.04
Abnormal excretion of the isomers of urinary coproporphyrin by patients with Dubin-Johnson syndrome in Israel. Clin Sci (1971) 1.03
Local application of honey for treatment of neonatal postoperative wound infection. Acta Paediatr (1998) 1.03
Transillumination of the palm for venipuncture in infants. Pediatr Emerg Care (2001) 1.03
Removal of silicone oil in the management of glaucoma in eyes with emulsified silicone. Retina (1993) 1.03
Hypocholesterolemic effect of lycopene and beta-carotene is related to suppression of cholesterol synthesis and augmentation of LDL receptor activity in macrophages. Biochem Biophys Res Commun (1997) 1.02
Expression and DNA sequence analysis of a human embryonic skeletal muscle myosin heavy chain gene. Nucleic Acids Res (1989) 1.02
Increased plasma and lipoprotein lipid peroxidation in apo E-deficient mice. Biochem Biophys Res Commun (1994) 1.02
Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy. Clin Biochem (1982) 1.02
The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation. Genomics (1998) 1.02
Predicting deterioration in previously healthy infants hospitalized with respiratory syncytial virus infection. Pediatrics (1999) 1.00
Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest (1999) 1.00
Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides. Acta Paediatr Scand (1978) 1.00
Handwashing patterns in primary pediatric community clinics. Infection (1998) 1.00
A locus for primary ciliary dyskinesia maps to chromosome 19q. J Med Genet (2000) 0.99
Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice. Biochem Biophys Res Commun (1994) 0.99
Severe Clostridium difficile-associated colitis in young patients with cystic fibrosis. J Pediatr (1998) 0.98